Shots:
J&J has entered into a definitive agreement to acquire Halda Therapeutics, strengthening its oncology pipeline
As per the deal, J&J will acquire Halda for $3.05B in cash, with the deal treated as a business combination & expected to close in the coming months
Acquisition will add Halda’s Regulated Induced Proximity TArgeting Chimera (RIPTAC) platform…
